FDA Approves Injectable Version of Bristol Myers’ Opdivo
The U.S. Food and Drug Administration announced on Friday the approval of an injectable formulation of Bristol Myers Squibb’s popular cancer medication, Opdivo.
Source link
The U.S. Food and Drug Administration announced on Friday the approval of an injectable formulation of Bristol Myers Squibb’s popular cancer medication, Opdivo.
Source link